Chartis published implications and next steps regarding 340B policies in this week's Chartis Top Reads.
Public source
Publisher name
Public post
As multiple new 340B policies could coincide in 2027, providers face impacts to their eligibility, reimbursement levels, cash flow, and administrative burdens. We discus…
Company
Chartis
Transforming US Healthcare is one of the great challenges of our time. We believe it can be done, and we can help.
- Industry
- Business Consulting and Services
- Location
- Chicago, US
- Company size
- 1,001–5,000 employees
About Chartis
The challenges facing US healthcare are longstanding and all too familiar. We are Chartis, and we believe in better. We work with over 1,900 clients annually to develop and activate transformative strategies, operating models, and organizational enterprises that make U.S. healthcare more affordable, accessible, safe, and human. With over 1,450 professionals, we help providers, payers, technology innovators, retail companies, and investors create and embrace solutions that tangibly and materially reshape healthcare for the better. Our family of brands—Chartis, Jarrard, Greeley, and HealthScape Advisors—is 100% focused on healthcare and each has a longstanding commitment to helping transform healthcare in big and small ways. Chartis. Believe in better.
See moreLatest activity
Latest activity from Chartis
6 signals
Products & Services
Chartis has developed HealthCare360, a framework examining healthcare forces, patient experience, physician experience, organizational performance, and long-term sustainability.
People
Chartis employee Katie Hearn helped build a unified problem-solving framework for the team.
Research & Knowledge
Chartis published a thought leadership exploring a better model of care considering changes in demographics, technology, and investment.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Charles River Associates
Charles River Associates published an infographic by Matthew Majewski detailing the key differences and strategic implications of the new 340B Rebate Model Pilot Program.
Research & Knowledge
Health Advances
Health Advances published the latest edition of its Sharp Strategy Spotlight, highlighting healthcare industry trends, policies, and developments.
Research & Knowledge
Reid Strategic
Reid Strategic published a post describing the confluence of events that made #340B one of the hottest elements of healthcare issues.
Research & Knowledge
FTI Consulting
FTI Consulting published a research piece by Meredith Rarus and Steven Kouril examining DME overpayments driven by gaps in patient visibility, documentation timing, and supplier actions.
Research & Knowledge
RxParadigm